about
Virus-induced secondary bacterial infection: a concise reviewPandemic influenza and healthcare demand in the Netherlands: scenario analysisSeasonal, avian, and novel H1N1 influenza: prevention and treatment modalities.Oseltamivir PK/PD Modeling and Simulation to Evaluate Treatment Strategies against Influenza-Pneumococcus Coinfection.Detection sensitivity of influenza rapid diagnostic testsPublished sequences do not support transfer of oseltamivir resistance mutations from avian to human influenza A virus strains.Insight into alternative approaches for control of avian influenza in poultry, with emphasis on highly pathogenic H5N1Antiviral treatment of influenza in South Korea.Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions.Oseltamivir reduces hippocampal abnormal EEG activities after a virus infection (influenza) in isoflurane-anesthetized rats.Adverse drug reaction profile of oseltamivir in children.Reactivity and sensitivity of commercially available influenza rapid diagnostic tests in Japan.Zoonotic Potential of Influenza A Viruses: A Comprehensive OverviewAntivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC E): the ALIC E protocolImpact of time to treatment of oseltamivir on influenza hospitalization cost among Korean children
P2860
Q26783333-611E3812-6644-40B7-9197-FF8C5F23EEF5Q30233416-A842C5A8-5E9F-4CC6-969D-2DBC97044C64Q30382632-38EF7BA4-2AB6-4EB7-A6C2-9A850BD19978Q30390145-AB370904-241B-4C15-8D9C-A1A708F8C4F1Q34381616-BAA489EE-353A-46F4-82DB-E9D29EAD30B9Q35607731-64664D35-873B-4EB4-BD80-679325BBCCB1Q36432764-F31C9959-5F10-4BC2-B03B-8AC7887C60EFQ38401883-789CD3B9-3836-457B-A6FC-76E5F5C1AC13Q39452637-7E91C100-2610-4ED8-8729-0E3905550141Q39761289-E3ED35E9-8816-407D-8AED-50AE20D5C868Q41807747-B4F0DD9F-712B-424A-911C-493610C9E419Q46682788-648C5007-C1D2-4203-AF80-FCEED25DC739Q57093653-62FCAAE1-BBDF-4BBA-8037-93DA772CF12FQ57094242-E0672D9B-BF9F-4AE5-ACFC-4B52D3A20419Q58483941-B0C97391-F3B0-4DEA-B5C4-BBC27857A191
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Neuraminidase inhibitors: zanamivir and oseltamivir.
@ast
Neuraminidase inhibitors: zanamivir and oseltamivir.
@en
type
label
Neuraminidase inhibitors: zanamivir and oseltamivir.
@ast
Neuraminidase inhibitors: zanamivir and oseltamivir.
@en
prefLabel
Neuraminidase inhibitors: zanamivir and oseltamivir.
@ast
Neuraminidase inhibitors: zanamivir and oseltamivir.
@en
P2860
P356
P1476
Neuraminidase inhibitors: zanamivir and oseltamivir.
@en
P2093
I R McNicholl
J J McNicholl
P2860
P356
10.1345/APH.10118
P407
P577
2001-01-01T00:00:00Z